University of Cape Coast Institutional Repository

Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy

Show simple item record

dc.contributor.author Acheampong, Desmond O.
dc.contributor.author Adokoh, Christian K.
dc.contributor.author Ampomah, Paulina
dc.contributor.author Agyirifo, Daniel S.
dc.contributor.author Dadzie, Isaac
dc.contributor.author Ackah, Francis A.
dc.contributor.author Asiamah, Ernest A.
dc.date.accessioned 2023-10-17T16:30:06Z
dc.date.available 2023-10-17T16:30:06Z
dc.date.issued 2017
dc.identifier.uri http://hdl.handle.net/123456789/9583
dc.description.abstract Abstract: Antibodies have become the preferred therapeutic treatment option for cancers. Antibody therapy is associated with low toxic profile and specific in its activity, unlike chemotherapy and ra- diotherapy. Types of tumor are known to express multiple receptors that cross-talk to activate per- petual growth, proliferation and metastasis, and inhibit apoptosis in such tumors. Bispecific antibod- ies (BsAbs) are therefore the preferred agent for the treatment of such cancers due to its unique char- acteristics. This review discusses up to date therapeutic potentials of BsAbs. en_US
dc.language.iso en en_US
dc.publisher Protein & Peptide Letters en_US
dc.subject Antibody, en_US
dc.subject bispecific antibody (BsAb), en_US
dc.subject immunotherapeutic agent, en_US
dc.subject cancer therapy, en_US
dc.subject diabody, en_US
dc.subject antitumor. en_US
dc.title Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UCC IR


Advanced Search

Browse

My Account